L. G. Payne

Statistics

Publications

Citations

812

H-Index

Active since

1979

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

L. G. Payne is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in enzyme inhibition, pharmacology, and medicinal chemistry.

Publications per year

1979–1991

Publications

A new class of angiotensin-converting enzyme inhibitors

Arthur A. Patchett, Elbert E. Harris, Edward W. Tristram et al. · Nature · 1980 · 706 citations

Medicine, Medicinal Chemistry, Pharmacology +8

Inhibition of thermolysin by N-carboxymethyl dipeptides

Alan L. Maycock, Donna M. DeSousa, L. G. Payne et al. · Biochemical and Biophysical Research Communications · 1981 · 56 citations

Life Sciences, Biochemistry, Enzymology +6

Synthesis of N2-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl-L-proline (Lisinopril)

Mingshu Wu, A. W. DOUGLAS, Debra L. Ondeyka et al. · Journal of Pharmaceutical Sciences · 1985 · 30 citations

Natural Sciences, Chemistry, Pharmacology +2

1-(Substituted)benzyl-5-aminoimidazole-4-carboxamides are potent orally active inhibitors ofTrypanosoma cruzi in mice

John C. Chabala, Virginia B. Waits, Theodore J. Ikeler et al. · Cellular and Molecular Life Sciences · 1991 · 10 citations

Medicine, Medicinal Chemistry, Pharmacology +8

A new one‐step synthesis of 2,3‐dihydro‐5H‐thiazolo[2,3‐b]quinazolin‐5‐one and 3,4‐dihydro‐2h,6h[1,3]thiazino[2,3‐b] quinazolin‐6‐one

L. G. Payne, J. Przytycki, A. A. PATCHETT et al. · Journal of Heterocyclic Chemistry · 1979 · 10 citations

Natural Sciences, Chemistry, Medicinal Chemistry +5

1–5 of 5